Autolus Therapeutics plc
AUTL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001730463
In the last 90 days, Autolus Therapeutics plc insiders filed 0 open-market purchases and 1 sale; 83 institutions reported holding it in 13F filings for Q2 2026, worth $212.0M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Autolus Therapeutics plc as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 69
- +5 vs. Q1 2023
- Shares held
- 109.4M
- +5.84M (+5.6%) vs. Q1 2023
- Total value
- $260.4M
- +$69.8M (+36.6%) vs. Q1 2023
- New holders
- 13
- 19 more added
- Sold out
- 8
- 17 more reduced
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AUTL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 83 | $212.0M |
| Q1 2026 | 84 | $184.4M |
| Q4 2025 | 89 | $277.1M |
| Q3 2025 | 96 | $235.7M |
| Q2 2025 | 94 | $378.6M |
| Q1 2025 | 95 | $261.0M |
| Q4 2024 | 110 | $395.4M |
| Q3 2024 | 101 | $648.5M |
| Q2 2024 | 111 | $620.0M |
| Q1 2024 | 120 | $1.12B |
| Q4 2023 | 99 | $746.6M |
| Q3 2023 | 71 | $258.1M |
| Q2 2023 | 69 | $260.4M |
| Q1 2023 | 65 | $195.1M |
| Q4 2022 | 71 | $204.2M |
| Q3 2022 | 66 | $105.7M |
| Q2 2022 | 67 | $143.9M |
| Q1 2022 | 66 | $228.6M |
| Q4 2021 | 73 | $272.3M |
| Q3 2021 | 59 | $164.2M |
| Q2 2021 | 69 | $169.6M |
| Q1 2021 | 63 | $129.4M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Autolus Therapeutics plc; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Syncona Portfolio Ltd | 21,346,829 | $50.8M | 76.58% | 00.0% | Unchanged |
| Blackstone Group Inc. | 20,485,611 | $48.8M | 0.21% | 00.0% | Unchanged |
| Deep Track Capital, LP | 15,000,000 | $35.7M | 1.67% | 00.0% | Unchanged |
| Polygon Management Ltd. | 12,000,000 | $28.6M | 3.86% | +2,000,000+20.0% | Added |
| Paradigm Biocapital Advisors LP | 9,217,150 | $21.9M | 1.78% | +9,217,150 | New |
| Armistice Capital, LLC | 7,264,000 | $17.3M | 0.43% | −2,408,000−24.9% | Reduced |
| Nantahala Capital Management, LLC | 4,272,203 | $10.2M | 1.23% | −3,419,610−44.5% | Reduced |
| Frazier Life Sciences Management, L.P. | 3,746,857 | $8.92M | 0.53% | 00.0% | Unchanged |
| Perpetual Ltd | 1,996,355 | $4.75M | 0.04% | +138,264+7.4% | Added |
| Schroder Investment Management Group | 1,672,732 | $3.98M | 0.01% | 00.0% | Unchanged |
| Affinity Asset Advisors, LLC | 1,589,017 | $3.78M | 1.49% | +1,589,017 | New |
| Laurion Capital Management LP | 1,500,000 | $3.57M | 0.15% | 00.0% | Unchanged |
| DAFNA Capital Management LLC | 930,394 | $2.21M | 0.61% | −245,756−20.9% | Reduced |
| BlackRock Inc. | 870,994 | $2.07M | 0.00% | −14,503−1.6% | Reduced |
| ExodusPoint Capital Management, LP | 777,760 | $1.85M | 0.02% | +363,996+88.0% | Added |
| Alphabet Inc. | 698,262 | $1.66M | 0.09% | 00.0% | Unchanged |
| Odey Asset Management LLP | 658,995 | $1.57M | 0.58% | +658,995 | New |
| LGT Capital Partners Ltd. | 550,000 | $1.31M | 0.05% | 00.0% | Unchanged |
| UBS Oconnor LLC | 530,919 | $1.26M | 0.03% | −226,089−29.9% | Reduced |
| Wells Fargo & Company | 519,442 | $1.24M | 0.00% | +32,073+6.6% | Added |
| MAI Capital Management | 401,496 | $955.6K | 0.01% | −32,169−7.4% | Reduced |
| Cormorant Asset Management, LP | 392,167 | $933.4K | 0.05% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 308,787 | $734.9K | 0.00% | +215,348+230.5% | Added |
| Ikarian Capital, LLC | 260,087 | $619.0K | 0.22% | 00.0% | Unchanged |
| Harbor Capital Advisors, Inc. | 244,541 | $582.0K | 0.12% | +22,392+10.1% | Added |
| Erste Asset Management GmbH | 195,000 | $444.6K | 0.01% | 00.0% | Unchanged |
| Citadel Advisors LLC | 185,815 | $442.2K | 0.00% | −1,379,531−88.1% | Reduced |
| Edentree Asset Management Ltd | 180,000 | $430.2K | 0.15% | +180,000 | New |
| Morgan Stanley | 160,314 | $381.5K | 0.00% | +103,917+184.3% | Added |
| Renaissance Technologies LLC | 151,200 | $360.0K | 0.00% | +42,800+39.5% | Added |
| Cetera Investment Advisers | 135,200 | $321.8K | 0.00% | −6,400−4.5% | Reduced |
| Alps Advisors Inc | 127,220 | $302.8K | 0.00% | +127,220 | New |
| Geode Capital Management, LLC | 112,945 | $268.8K | 0.00% | +59,209+110.2% | Added |
| Mariner, LLC | 101,000 | $240.0K | 0.00% | +101,000 | New |
| Goldman Sachs Group Inc | 93,195 | $221.8K | 0.00% | +71,378+327.2% | Added |
| Leonteq Securities AG | 75,000 | $178.5K | 0.02% | −25,000−25.0% | Reduced |
| UBS Group AG | 70,093 | $166.8K | 0.00% | +5,726+8.9% | Added |
| Privium Fund Management B.V. | 67,577 | $154.1K | 0.04% | 00.0% | Unchanged |
| Innovis Asset Management LLC | 63,179 | $150.4K | 0.06% | −62,927−49.9% | Reduced |
| State Street Corp | 52,387 | $124.7K | 0.00% | −48,860−48.3% | Reduced |
| Exchange Traded Concepts, LLC | 49,527 | $117.9K | 0.00% | +49,527 | New |
| LPL Financial LLC | 48,675 | $115.8K | 0.00% | +13,350+37.8% | Added |
| Wealth Effects LLC | 47,000 | $111.9K | 0.05% | +2,000+4.4% | Added |
| Boothbay Fund Management, LLC | 27,215 | $64.8K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 26,400 | $62.8K | 0.00% | +12,700+92.7% | Added |
| Marshall Wace, LLP | 25,496 | $60.7K | 0.00% | +25,496 | New |
| Tower Research Capital LLC (TRC) | 25,376 | $60.4K | 0.00% | −4,352−14.6% | Reduced |
| Jane Street Group, LLC | 23,265 | $55.4K | 0.00% | −72,611−75.7% | Reduced |
| National Asset Management, Inc. | 22,000 | $52.4K | 0.00% | +22,000 | New |
| Qube Research & Technologies Ltd | 21,907 | $52.1K | 0.00% | +21,907 | New |
| Advisor Group Holdings, Inc. | 17,250 | $41.1K | 0.00% | +325+1.9% | Added |
| Blair William & Co | 13,107 | $31.2K | 0.00% | 00.0% | Unchanged |
| United Bank | 11,500 | $27.4K | 0.00% | +1,200+11.7% | Added |
| Invesco Ltd. | 10,699 | $25.5K | 0.00% | +10,699 | New |
| Lazard Asset Management LLC | 10,551 | $24.0K | 0.00% | +383+3.8% | Added |
| Focused Wealth Management, Inc | 5,000 | $11.9K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 4,835 | $11.5K | 0.00% | +4,182+640.4% | Added |
| Quadrant Capital Group LLC | 3,024 | $7.20K | 0.00% | −850−21.9% | Reduced |
| Lindbrook Capital, LLC | 1,935 | $4.61K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 1,799 | $4.28K | 0.00% | −439,226−99.6% | Reduced |
| Rhumbline Advisers | 1,228 | $2.92K | 0.00% | +1,228 | New |
| FMR LLC | 1,133 | $2.70K | 0.00% | 00.0% | Unchanged |
| Ulland Investment Advisors, LLC | 1,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| Carmichael Hill & Associates, Inc. | 508 | $1.21K | 0.00% | 00.0% | Unchanged |
| Close Asset Management Ltd | 500 | $1.00K | 0.00% | 00.0% | Unchanged |
| State of Wyoming | 300 | $714 | 0.00% | +90+42.9% | Added |
| Northwestern Mutual Wealth Management Co | 100 | $238 | 0.00% | +100 | New |
| Huntington National Bank | 1 | $2 | 0.00% | −1,500−99.9% | Reduced |
| Royal Bank of Canada | 16 | $0 | 0.00% | −19,996−99.9% | Reduced |
| Millennium Management LLC | 0 | $0 | 0.00% | −360,145−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −214,300−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −133,860−100.0% | Sold out |
| Boulder Hill Capital Management LP | 0 | $0 | 0.00% | −57,191−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −38,947−100.0% | Sold out |
| Cannell Capital LLC | 0 | $0 | 0.00% | −16,835−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −12,192−100.0% | Sold out |
| Bayshore Asset Management, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Odey Asset Management Group Ltd | – | – | – | – | Not filed |